• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存数据的时间依赖性判别指数。

A time-dependent discrimination index for survival data.

作者信息

Antolini Laura, Boracchi Patrizia, Biganzoli Elia

机构信息

Unità di Statistica Medica e Biometria, Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano, Via Venezian 1, 20133 Milano, Italy.

出版信息

Stat Med. 2005 Dec 30;24(24):3927-44. doi: 10.1002/sim.2427.

DOI:10.1002/sim.2427
PMID:16320281
Abstract

To derive models suitable for outcome prediction, a crucial aspect is the availability of appropriate measures of predictive accuracy, which have to be usable for a general class of models. The Harrell's C discrimination index is an extension of the area under the ROC curve to the case of censored survival data, which owns a straightforward interpretability. For a model including covariates with time-dependent effects and/or time-dependent covariates, the original definition of C would require the prediction of individual failure times, which is not generally addressed in most clinical applications. Here we propose a time-dependent discrimination index Ctd where the whole predicted survival function is utilized as outcome prediction, and the ability to discriminate among subjects having different outcome is summarized over time. Ctd is based on a novel definition of concordance: a subject who developed the event should have a less predicted probability of surviving beyond his/her survival time than any subject who survived longer. The predicted survival function of a subject who developed the event is compared to: (1) that of subjects who developed the event before his/her survival time, and (2) that of subjects who developed the event, or were censored, after his/her survival time. Subjects who were censored are involved in comparisons with subjects who developed the event before their observed times. The index reduces to the previous C in the presence of separation between survival curves on the whole follow-up. A confidence interval for Ctd is derived using the jackknife method on correlated one-sample U-statistics.The proposed index is used to evaluate the discrimination ability of a model, including covariates having time-dependent effects, concerning time to relapse in breast cancer patients treated with adjuvant tamoxifen. The model was obtained from 596 patients entered prospectively at Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano (INT). The model discrimination ability was validated on an independent testing data set of 175 patients provided by Centro Regionale Indicatori Biochimici di Tumore (CRIBT) in Venice.

摘要

为了推导适用于结果预测的模型,一个关键方面是要有合适的预测准确性度量指标,这些指标必须适用于一般类别的模型。哈雷尔C判别指数是将ROC曲线下面积扩展到删失生存数据的情况,它具有直接的可解释性。对于包含具有时间依赖性效应的协变量和/或时间依赖性协变量的模型,C的原始定义需要预测个体失效时间,而这在大多数临床应用中通常并未涉及。在此,我们提出一个时间依赖性判别指数Ctd,其中整个预测生存函数被用作结果预测,并且在不同时间总结区分具有不同结果的受试者的能力。Ctd基于一种新的一致性定义:发生事件的受试者在其生存时间之后存活的预测概率应低于任何存活时间更长的受试者。将发生事件的受试者的预测生存函数与以下两者进行比较:(1)在其生存时间之前发生事件的受试者的预测生存函数,以及(2)在其生存时间之后发生事件或被删失的受试者的预测生存函数。被删失的受试者参与与在其观察时间之前发生事件的受试者的比较。在整个随访期间生存曲线存在分离的情况下,该指数简化为先前的C。使用关于相关单样本U统计量的刀切法得出Ctd的置信区间。所提出的指数用于评估一个模型的判别能力,该模型包括具有时间依赖性效应的协变量,涉及接受辅助他莫昔芬治疗的乳腺癌患者的复发时间。该模型来自于米兰国立肿瘤研究所(INT)前瞻性纳入的596例患者。模型判别能力在威尼斯的区域肿瘤生物化学指标中心(CRIBT)提供的175例患者的独立测试数据集上得到验证。

相似文献

1
A time-dependent discrimination index for survival data.生存数据的时间依赖性判别指数。
Stat Med. 2005 Dec 30;24(24):3927-44. doi: 10.1002/sim.2427.
2
Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.美国癌症协会关于空气污染颗粒与死亡率关系研究的长期随访及空间分析
Res Rep Health Eff Inst. 2009 May(140):5-114; discussion 115-36.
3
Estimating the proportion of cured patients in a censored sample.估计截尾样本中治愈患者的比例。
Stat Med. 2005 Jun 30;24(12):1865-79. doi: 10.1002/sim.2137.
4
Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.评估胆囊癌辅助放疗生存获益的预测模型
J Clin Oncol. 2008 May 1;26(13):2112-7. doi: 10.1200/JCO.2007.14.7934. Epub 2008 Mar 31.
5
Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.中国人群肾切除术后非转移性肾细胞癌当前预后模型的验证:一项15年单中心经验
Int J Urol. 2009 Mar;16(3):268-73. doi: 10.1111/j.1442-2042.2008.02229.x. Epub 2008 Dec 14.
6
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.基于新辅助内分泌治疗后肿瘤特征的雌激素受体阳性乳腺癌预后预测
J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.
7
Regression analysis of doubly censored failure time data with frailty.具有脆弱性的双重删失失效时间数据的回归分析
Biometrics. 2006 Jun;62(2):458-64. doi: 10.1111/j.1541-0420.2005.00487.x.
8
Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.黏液样/圆形细胞和多形性脂肪肉瘤:单机构治疗的一系列患者的预后因素和生存率
Cancer. 2007 Jun 15;109(12):2522-31. doi: 10.1002/cncr.22720.
9
A fast routine for fitting Cox models with time varying effects of the covariates.一种用于拟合具有协变量时变效应的Cox模型的快速程序。
Comput Methods Programs Biomed. 2006 Feb;81(2):154-61. doi: 10.1016/j.cmpb.2005.11.006. Epub 2006 Jan 19.
10
Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.预测食管腺癌或胃食管交界腺癌行根治性食管切除术后的个体生存情况。
Ann Surg. 2008 Dec;248(6):1006-13. doi: 10.1097/SLA.0b013e318190a0a2.

引用本文的文献

1
An Effective Meaningful Way to Evaluate Survival Models.一种评估生存模型的有效且有意义的方法。
Proc Mach Learn Res. 2023 Jul;202:28244-28276.
2
Statistical learning methods for improving predictive performance in time-dependent survival models.用于提高时间相依生存模型预测性能的统计学习方法。
Genomics Inform. 2025 Sep 1;23(1):19. doi: 10.1186/s44342-025-00050-7.
3
Histopathology-based protein multiplex generation using deep learning.利用深度学习基于组织病理学生成蛋白质多重分析
Nat Mach Intell. 2025;7(8):1292-1307. doi: 10.1038/s42256-025-01074-y. Epub 2025 Aug 4.
4
Liver metastases in thyroid cancer: epidemiology, risk stratification and survival outcomes in the immunotherapy era.甲状腺癌的肝转移:免疫治疗时代的流行病学、风险分层及生存结局
Front Immunol. 2025 Jul 25;16:1624181. doi: 10.3389/fimmu.2025.1624181. eCollection 2025.
5
Deep learning to predict progression independent of relapse activity at a first demyelinating event.深度学习用于预测首次脱髓鞘事件中与复发活动无关的疾病进展。
Brain Commun. 2025 Jul 4;7(4):fcaf243. doi: 10.1093/braincomms/fcaf243. eCollection 2025.
6
Limitations of Binary Classification for Long-Horizon Diagnosis Prediction and Advantages of a Discrete-Time Time-to-Event Approach: Empirical Analysis.长期诊断预测的二元分类局限性及离散时间事件发生时间方法的优势:实证分析
JMIR AI. 2025 Mar 27;4:e62985. doi: 10.2196/62985.
7
Exploring trade-offs in equitable stroke risk prediction with parity-constrained and race-free models.利用平等约束和无种族模型探索公平性中风风险预测中的权衡。
Artif Intell Med. 2025 Jun;164:103130. doi: 10.1016/j.artmed.2025.103130. Epub 2025 Apr 10.
8
Federated transfer learning with differential privacy for multi-omics survival analysis.用于多组学生存分析的具有差分隐私的联邦迁移学习
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf166.
9
A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables.使用多组学整合和临床变量进行癌症生存预测的综合综述。
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf150.
10
Measuring the Performance of Survival Models to Personalize Treatment Choices.评估生存模型的性能以实现个性化治疗选择。
Stat Med. 2025 Mar 30;44(7):e70050. doi: 10.1002/sim.70050.